One of DFW's newest public companies broadens board with addition of two women

Taysha Gene Therapies — which held its IPO in September — adds Kathy Reape and Laura Sepp-Lorenzino to the young company’s director lineup.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.